Gufic Biosciences Limited — Others, 28-12-2024: Trading Window

Gufic Biosciences Limited has communicated the closure of its trading window for designated persons and their immediate relatives from January 1, 2025, until 48 hours post the announcement of its financial results for the quarter and nine months ending December 31, 2024. This measure aligns with internal compliance protocols aimed at preventing insider trading.

Investors may view this as a proactive step in governance, although it introduces a temporary restriction on share transactions, which could impact liquidity. Overall, the strategic focus on compliance enhances governance integrity, potentially fostering a positive outlook among stakeholders.